Skip to content

Intergard HEWAA2410080810/1Recalls & reported problems

Intervascular Sas · Intergard Woven Aortic Arch Collagen Coated Vascular Graft · Class 2 · Implant

All models of Intergard (41)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
7
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00384401010739), received between Dec 14, 2015 and Aug 14, 2024 — classified as 3 injuries, 4 malfunctions.

The most frequently reported specific device problem is “Device Damaged Prior to Use” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Damaged Prior to Use2
  • Insufficient Device Problem Information2
  • Off-Label Use2
  • Flaked1
  • Manufacturing, Packaging or Shipping Problem1
  • Product Quality Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • Hemorrhage/Blood Loss/Bleeding2
  • Blood Loss1
  • No Patient Involvement1

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 14, 2024Flaked; Flaked

    FOLLOW UP 1: COMPLAINT#: (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19979706 ↗
  • InjuryMar 30, 2022Off-Label Use; Insufficient Device Problem Information; Off-Label Use; Insufficient Device Problem Information

    DURING THE SURGERY, THE SURGEON NOTICED A BLEEDING AROUND THE GRAFT. THE GRAFT WAS THEN REPLACED BY ANOTHER ONE TO COMPLETE THE SURGERY. THERE IS NO INDICATION OF ACTUAL OR POTENTIAL FOR HARM OR DEATH

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 13950196 ↗
  • InjuryMar 25, 2022Off-Label Use; Insufficient Device Problem Information; Off-Label Use; Insufficient Device Problem Information

    DURING THE SURGERY, THE SURGEON NOTICED A BLEEDING AROUND THE GRAFT. THE GRAFT WAS THEN REPLACED BY ANOTHER ONE TO COMPLETE THE SURGERY. THERE IS NO INDICATION OF ACTUAL OR POTENTIAL FOR HARM OR DEATH.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 13904600 ↗
  • MalfunctionNov 29, 2021Device Damaged Prior to Use; Device Damaged Prior to Use

    ARTICLE HEWAA2410080810 / 1 (B)(4). PACKAGING ARRIVED DAMAGED, CUSTOMER WANTS TO RETURN GOODS. (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12880458 ↗
  • MalfunctionApr 23, 2021Device Damaged Prior to Use; Device Damaged Prior to Use

    WHEN THE CUSTOMER (DISTRIBUTOR) CHECKED THE RECEIVED GOODS, HE FOUND A PRODUCT BOX DAMAGED. ACCORDING TO THE CUSTOMER, THE SHIPPING BOX OUTSIDE WAS INTACT. COMPLAINT # (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11715363 ↗
  • MalfunctionDec 10, 2020Product Quality Problem; Product Quality Problem

    SEE INITIAL MFR REPORT #1640201-2020-00023 (COMPLAINT #(B)(4)).

    Patient problems: No Patient Involvement

    MAUDE report 10984179 ↗
  • InjuryDec 14, 2015Manufacturing, Packaging or Shipping Problem

    DURING AN ARCH REPLACEMENT PERFORMED ON (B)(6) 2015 TO REPAIR AN AORTIC DISSECTION, IT WAS REPORTED THAT THE PATIENT EXPERIENCED INTRAOPERATIVE BLEEDING ESPECIALLY THROUGH THE NEEDLE HOLES (500-600 ML/H). PLATELET AND COAGULATION FACTOR WERE USED TO STOP THE BLEEDING. THE DURATION OF THE OPERATION WAS ABOUT 3 HOURS WITH NOTHING ABNORMAL. UNFORTUNATELY, THE HEMOSTATIC EFFECT WAS NOT GOOD, THE PATIENT EVENTUALLY DIED OF HEMORRHAGIC SHOCK. ADDITIONAL CLINICAL INFORMATION INDICATED THAT ANTICOAGULANT MEDICATION WAS USED BEFORE SURGERY, THE ACT RANGE DURING EXTRACORPOREAL CIRCULATION WAS EXTREMELY HIGH AND THE PLATELET DATA OF THE PATIENT WAS LOW.

    Patient problems: Blood Loss

    MAUDE report 5293011 ↗

Other Prosthesis, Vascular Graft, Of 6mm And Greater Diameter devices

All Prosthesis, Vascular Graft, Of 6mm And Greater Diameter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page